Collaboration on the optimisation of macromolecular pharmaceutical access to cellular targets (COMPACT)

01 November 2012 → 31 October 2017
European funding: various
Research disciplines
  • Medical and health sciences
    • Biomarker discovery and evaluation
    • Drug discovery and development
    • Medicinal products
    • Pharmaceutics
    • Pharmacognosy and phytochemistry
    • Pharmacology
    • Pharmacotherapy
    • Toxicology and toxinology
    • Other pharmaceutical sciences
biopharmaceuticals biobarriers nanomedicines
Project description

Many new medicines are based on biological molecules such as proteins, peptides or nucleic acids. The goal is to investigate the obstacles these drugs (a.k.a. biopharmaceuticals) need to overcome in order to reach their intended target site in the body. The team will then use this information to develop biopharmaceutical formulations to deliver these novel drugs to their targets.